
Michael S. Brooke
Examiner (ID: 8555)
| Most Active Art Unit | 2853 |
| Art Unit(s) | 2853 |
| Total Applications | 507 |
| Issued Applications | 449 |
| Pending Applications | 14 |
| Abandoned Applications | 44 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19717263
[patent_doc_number] => 12202786
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-21
[patent_title] => Method for producing aromatic nitrile compound and method for producing carbonate ester
[patent_app_type] => utility
[patent_app_number] => 18/140333
[patent_app_country] => US
[patent_app_date] => 2023-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 11071
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 231
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18140333
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/140333 | Method for producing aromatic nitrile compound and method for producing carbonate ester | Apr 26, 2023 | Issued |
Array
(
[id] => 19353056
[patent_doc_number] => 12053481
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-06
[patent_title] => Compositions and methods for deep dermal drug delivery
[patent_app_type] => utility
[patent_app_number] => 18/124906
[patent_app_country] => US
[patent_app_date] => 2023-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 10099
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18124906
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/124906 | Compositions and methods for deep dermal drug delivery | Mar 21, 2023 | Issued |
Array
(
[id] => 18575439
[patent_doc_number] => 11731951
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-08-22
[patent_title] => Water reactivity with natural products
[patent_app_type] => utility
[patent_app_number] => 18/117579
[patent_app_country] => US
[patent_app_date] => 2023-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2955
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18117579
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/117579 | Water reactivity with natural products | Mar 5, 2023 | Issued |
Array
(
[id] => 20402210
[patent_doc_number] => 12492178
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Stable polymorph of R-MDMA HCl
[patent_app_type] => utility
[patent_app_number] => 18/116195
[patent_app_country] => US
[patent_app_date] => 2023-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7136
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18116195
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/116195 | Stable polymorph of R-MDMA HCl | Feb 28, 2023 | Issued |
Array
(
[id] => 19808279
[patent_doc_number] => 12239638
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-04
[patent_title] => Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
[patent_app_type] => utility
[patent_app_number] => 18/115436
[patent_app_country] => US
[patent_app_date] => 2023-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 14629
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18115436
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/115436 | Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound | Feb 27, 2023 | Issued |
Array
(
[id] => 18620387
[patent_doc_number] => 11753415
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => Compositions and methods for treating atopic dermatitis
[patent_app_type] => utility
[patent_app_number] => 18/110588
[patent_app_country] => US
[patent_app_date] => 2023-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17057
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18110588
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/110588 | Compositions and methods for treating atopic dermatitis | Feb 15, 2023 | Issued |
Array
(
[id] => 18620386
[patent_doc_number] => 11753414
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => Compositions and methods for treating atopic dermatitis
[patent_app_type] => utility
[patent_app_number] => 18/110577
[patent_app_country] => US
[patent_app_date] => 2023-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17061
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18110577
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/110577 | Compositions and methods for treating atopic dermatitis | Feb 15, 2023 | Issued |
Array
(
[id] => 19792151
[patent_doc_number] => 12233074
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-25
[patent_title] => Contraceptive methods with improved pearl index
[patent_app_type] => utility
[patent_app_number] => 18/107703
[patent_app_country] => US
[patent_app_date] => 2023-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7124
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18107703
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/107703 | Contraceptive methods with improved pearl index | Feb 8, 2023 | Issued |
Array
(
[id] => 18770785
[patent_doc_number] => 20230365575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => IMIDAZODIAZEPINEDIONES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/104610
[patent_app_country] => US
[patent_app_date] => 2023-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23138
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18104610
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/104610 | Imidazodiazepinediones and methods of use thereof | Jan 31, 2023 | Issued |
Array
(
[id] => 19418365
[patent_doc_number] => 20240294488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => ISOTOPOLOGES, SALTS, CRYSTALLINE FORMS, STEREOISOMERS, OF METHYLONE AND ETHYLONE AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/162591
[patent_app_country] => US
[patent_app_date] => 2023-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18162591
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/162591 | ISOTOPOLOGES, SALTS, CRYSTALLINE FORMS, STEREOISOMERS, OF METHYLONE AND ETHYLONE AND METHODS OF USE THEREOF | Jan 30, 2023 | Pending |
Array
(
[id] => 18692453
[patent_doc_number] => 20230322695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/161184
[patent_app_country] => US
[patent_app_date] => 2023-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26257
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 464
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18161184
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/161184 | Inhibitors of protein tyrosine phosphatase, compositions, and methods of use | Jan 29, 2023 | Issued |
Array
(
[id] => 19339273
[patent_doc_number] => 12049451
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-30
[patent_title] => Highly efficient process for the preparation of 4-Fluoro-1H-pyrazole or salts thereof
[patent_app_type] => utility
[patent_app_number] => 18/160323
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2650
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18160323
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/160323 | Highly efficient process for the preparation of 4-Fluoro-1H-pyrazole or salts thereof | Jan 26, 2023 | Issued |
Array
(
[id] => 18404540
[patent_doc_number] => 20230165891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => VIRUCIDAL COMPOSITIONS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/160650
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20902
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18160650
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/160650 | VIRUCIDAL COMPOSITIONS AND USE THEREOF | Jan 26, 2023 | Pending |
Array
(
[id] => 19793287
[patent_doc_number] => 12234216
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-25
[patent_title] => Isotopologues salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 18/147071
[patent_app_country] => US
[patent_app_date] => 2022-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 69
[patent_no_of_words] => 74656
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18147071
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/147071 | Isotopologues salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of use thereof | Dec 27, 2022 | Issued |
Array
(
[id] => 19226691
[patent_doc_number] => 12006324
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-06-11
[patent_title] => Preparation method of trilaciclib and precursors of trilaciclib
[patent_app_type] => utility
[patent_app_number] => 18/084179
[patent_app_country] => US
[patent_app_date] => 2022-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6483
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18084179
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/084179 | Preparation method of trilaciclib and precursors of trilaciclib | Dec 18, 2022 | Issued |
Array
(
[id] => 19628802
[patent_doc_number] => 12167678
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Organic electroluminescent materials and devices
[patent_app_type] => utility
[patent_app_number] => 18/065193
[patent_app_country] => US
[patent_app_date] => 2022-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11664
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 454
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18065193
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/065193 | Organic electroluminescent materials and devices | Dec 12, 2022 | Issued |
Array
(
[id] => 19411918
[patent_doc_number] => 12077725
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-03
[patent_title] => Ionizable cationic lipids
[patent_app_type] => utility
[patent_app_number] => 18/064565
[patent_app_country] => US
[patent_app_date] => 2022-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 16
[patent_no_of_words] => 26630
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18064565
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/064565 | Ionizable cationic lipids | Dec 11, 2022 | Issued |
Array
(
[id] => 18285649
[patent_doc_number] => 20230101121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => TREATING PATIENTS HARBORING AN ISOCITRATE DEHYDROGENASE-1 (IDH-1) MUTATION
[patent_app_type] => utility
[patent_app_number] => 17/986414
[patent_app_country] => US
[patent_app_date] => 2022-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17189
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17986414
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/986414 | TREATING PATIENTS HARBORING AN ISOCITRATE DEHYDROGENASE-1 (IDH-1) MUTATION | Nov 13, 2022 | Abandoned |
Array
(
[id] => 18333481
[patent_doc_number] => 20230125429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => TRIPTONIDE OR A COMPOSITION COMPRISING TRIPTONIDE FOR USE IN TREATING DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/983980
[patent_app_country] => US
[patent_app_date] => 2022-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19125
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17983980
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/983980 | TRIPTONIDE OR A COMPOSITION COMPRISING TRIPTONIDE FOR USE IN TREATING DISORDERS | Nov 8, 2022 | Pending |
Array
(
[id] => 18375884
[patent_doc_number] => 20230150965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => ISOTOPICALLY ENRICHED N-METHYL-1,3-BENZODIOXOLYLBUTANAMINE (MBDB) AND STEREOISOMERS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/982468
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17982468
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/982468 | ISOTOPICALLY ENRICHED N-METHYL-1,3-BENZODIOXOLYLBUTANAMINE (MBDB) AND STEREOISOMERS THEREOF | Nov 6, 2022 | Abandoned |